Carregant...

CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs

The endocannabinoid system is highly implicated in the development of insulin resistance associated with obesity. It has been shown that antagonism of the CB(1) receptor improves insulin sensitivity (S(I)). However, it is unknown whether this improvement is due to the direct effect of CB(1) blockade...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Stella P., Woolcott, Orison O., Hsu, Isabel R., Stefanoski, Darko, Harrison, L. Nicole, Zheng, Dan, Lottati, Maya, Kolka, Cathryn, Catalano, Karyn J., Chiu, Jenny D., Kabir, Morvarid, Ionut, Viorica, Bergman, Richard N., Richey, Joyce M.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3361982/
https://ncbi.nlm.nih.gov/pubmed/22374758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00496.2011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!